Bamco Inc Abb Vie Inc. Transaction History

Bamco Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $3.67 Million - $4.23 Million	-25,400 Reduced 62.87%	15,000 $2.39 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $1.06 Million - $1.28 Million	-7,700 Reduced 16.01%	40,400 $6.53 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $469,735 - $538,755	3,500 Added 7.85%	48,100 $6.46 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $1.93 Million - $2.45 Million	14,000 Added 45.75%	44,600 $6.83 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $4.04 Million - $5.01 Million	30,600 New	30,600 $4.96 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $58,163 - $68,455	-754 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $6,553 - $7,754	73 Added 10.72%	754 $70,000
Q1 2018 May 09, 2018	BUY	$92.01 - $123.21 $62,658 - $83,906	681 New	681 $64,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.